title: Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry).
authors.affiliation: Department of Internal Medicine I, University Hospital Rostock, Germany.
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Akin
authors.forename: Alexander
authors.initials: A
authors.lastname: Bufe
authors.forename: Lars
authors.initials: L
authors.lastname: Eckardt
authors.forename: Holger
authors.initials: H
authors.lastname: Reinecke
authors.forename: Jochen
authors.initials: J
authors.lastname: Senges
authors.forename: Gert
authors.initials: G
authors.lastname: Richardt
authors.forename: Karl-Heinz
authors.initials: KH
authors.lastname: Kuck
authors.forename: Steffen
authors.initials: S
authors.lastname: Schneider
authors.forename: Christoph A
authors.initials: CA
authors.lastname: Nienaber
mesh_terms: D000368:Aged; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D054855:Drug-Eluting Stents; D005260:Female; D005858:Germany; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D016015:Logistic Models; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D012042:Registries; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome; D050257:Tubulin Modulators / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D050257:Tubulin Modulators; D017239:Paclitaxel; D020123:Sirolimus